Hib-DTaP-poliovirus vaccine (Baxter international)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHib-DTaP-poliovirus vaccine (Baxter international)

Drug Alias NameHib-DTP-acellular-poliovirus vaccine-North American VaccineCertiva-IPV-HibDTaP-IPV-HibCertivaTM-IPV-HibHib-DTaP-IPV

ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesStatens Serum Institut Baxter International Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesStatens Serum Institut Aj Vaccines A/S Baxter International Inc

Active IndicationsN/A

Inactive IndicationsPoliomyelitisTetanusDiphtheria +[5]

Other Information

ATC CodeN/A